🥇 First rule of investing? Know when to save! Up to 55% off InvestingPro before BLACK FRIDAYCLAIM SALE

InVivo Therapeutics Holdings Corp (NVIVQ)

OTC Markets
Currency in USD
0.3700
0.0000(0.00%)
Closed

NVIVQ Income Statement

Advanced Income Statement
Period Ending:
2013
31/12
2014
31/12
2015
31/12
2016
31/12
2017
31/12
2018
31/12
2019
31/12
2020
31/12
2021
31/12
2022
31/12
Total Revenues
aa.aaaa.aaaa.aaaa.aaaa.aa-----
Total Revenues Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-----
Cost Of Revenues
aa.aaaa.aaaa.aaaa.aaaa.aa-----
Gross Profit
aa.aaaa.aaaa.aaaa.aaaa.aa-----
Gross Profit Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-----
Gross Profit Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa-----
Other Operating Expenses, Total
aa.aaaa.aaaa.aaaa.aaaa.aa12.7711.59.19.910.65
Other Operating Expenses, Total Growth
R&D Expenses
Selling General & Admin Expenses
Other Operating Expenses
aa.aaaa.aaaa.aaaa.aaaa.aa-46.12%-9.95%-20.88%+8.83%+7.58%
aa.aaaa.aaaa.aaaa.aaaa.aa4.935.63.944.385.23
aa.aaaa.aaaa.aaaa.aaaa.aa7.845.95.165.525.42
aa.aaaa.aaaa.aaaa.aaaa.aa-----
Operating Income
aa.aaaa.aaaa.aaaa.aaaa.aa-12.77-11.5-9.1-9.9-10.65
Operating Income Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+46.12%+9.95%+20.88%-8.83%-7.58%
EBIT Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa-----
Net Interest Expenses
aa.aaaa.aaaa.aaaa.aaaa.aa0.210.250.0200.15
Net Interest Expenses Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+77.5%+19.25%-92.52%-84.21%+4,933.33%
Interest Expense, Total
aa.aaaa.aaaa.aaaa.aaaa.aa-0.04----
Interest And Investment Income
aa.aaaa.aaaa.aaaa.aaaa.aa0.260.250.0200.15
Other Non Operating Expenses, Total
aa.aaaa.aaaa.aaaa.aaaa.aa-12.07-0.59000.01
EBT, Excl. Unusual Items
aa.aaaa.aaaa.aaaa.aaaa.aa-24.62-11.83-9.07-9.9-10.49
Gain (Loss) On Sale Of Assets
aa.aaaa.aaaa.aaaa.aaaa.aa-----
Other Unusual Items, Total
aa.aaaa.aaaa.aaaa.aaaa.aa1.2----
EBT, Incl. Unusual Items
aa.aaaa.aaaa.aaaa.aaaa.aa-23.42-11.83-9.07-9.9-10.49
EBT, Incl. Unusual Items Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+12.42%+49.49%+23.3%-9.05%-6.01%
EBT, Incl. Unusual Items Margin
aa.aaaa.aaaa.aaaa.aaaa.aa-----
Income Tax Expense
aa.aaaa.aaaa.aaaa.aaaa.aa-----
Net Income to Company
aa.aaaa.aaaa.aaaa.aaaa.aa-23.42-11.83-9.07-9.9-10.49
Minority Interest
aa.aaaa.aaaa.aaaa.aaaa.aa-----
Net Income
aa.aaaa.aaaa.aaaa.aaaa.aa-23.42-11.83-9.07-9.9-10.49
Net Income Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+12.42%+49.49%+23.3%-9.05%-6.01%
Net Income Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa-----
Preferred Dividend and Other Adjustments
aa.aaaa.aaaa.aaaa.aaaa.aa-----
Net Income to Common Excl. Extra Items
aa.aaaa.aaaa.aaaa.aaaa.aa-23.42-11.83-9.07-9.9-10.49
Basic EPS - Continuing Operations
aa.aaaa.aaaa.aaaa.aaaa.aa--881.91-32.86-7.48-6.83
Basic EPS - Continuing Operations Growth
aa.aaaa.aaaa.aaaa.aaaa.aa--+96.27%+77.25%+8.67%
Diluted EPS - Continuing Operations
aa.aaaa.aaaa.aaaa.aaaa.aa--881.91-32.86-7.48-6.83
Diluted EPS - Continuing Operations Growth
aa.aaaa.aaaa.aaaa.aaaa.aa--+96.27%+77.25%+8.67%
Basic Weighted Average Shares Outstanding
aa.aaaa.aaaa.aaaa.aaaa.aa-0.010.281.321.54
Diluted Weighted Average Shares Outstanding
aa.aaaa.aaaa.aaaa.aaaa.aa-0.010.281.321.54
Dividend Per Share
aa.aaaa.aaaa.aaaa.aaaa.aa-----
Dividend Per Share Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-----
EBITDA
aa.aaaa.aaaa.aaaa.aaaa.aa-12.68-11.44-9.05-9.86-10.59
EBITDA Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+45.6%+9.75%+20.88%-8.89%-7.45%
EBITDA Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa-----
EBIT
aa.aa